ureteric stones
Conditions
Interventions
Group A:Harnal(Tamsulosin)0.4mg,orally take once daily for four weeks.pain relief therapy with diclofenac suppository on demand
Group B:2 capsule placebo orally take once daily for four weeks.pain relief therapy with diclofenac suppository on demand
Sponsors
Urological stone Group of Chinese Urological Association
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Male and female aged 18 to 60 years old; 2. distal ureteric stone; 3. stones were 4-6mm in diameter; 4. Able and willing to provide signed informed consent.
Exclusion criteria
Exclusion criteria: 1. ureteric stone with complications; 2. with a history of ipsilateral ureteric surgery, spontaneous stone expulsion; 3. pregnant or breast-feeding patients; 4. More than twice higher than normal liver and kidney function; 5. known or suspected allergy to one of the study medications; 6. current use of alpha-adrenoceptor antagonists, beta blockers, calcium channel blockers or corticosteroids; 7. presence of fever, UTI, Pyonephrosis; 8. severe hydronephrosis,renal insufficiency, Renal atrophy; 9. solitary kidney, urethrostenosis,ureteric stricture; 10. gastric ulcer, diabetes mellitus, hypotension, blood disease; 11. Alcoholics, drug addicts; 12. Doctors think that patients not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall stone expulsion; | — |
Secondary
| Measure | Time frame |
|---|---|
| pain relief situation;mean analgesic consumption for renal colic recurrence;The rate of surgical intervention;mean stone-expulsion time; | — |
Countries
China
Contacts
Public ContactZhangqun Ye
Outcome results
None listed